276 related articles for article (PubMed ID: 19466948)
1. Protodynamic therapy for bladder cancer: in vitro results of a novel treatment concept.
Laihia JK; Pylkkänen L; Laato M; Boström PJ; Leino L
BJU Int; 2009 Nov; 104(9):1233-8. PubMed ID: 19466948
[TBL] [Abstract][Full Text] [Related]
2. Antitumor effects of cis-urocanic acid on experimental urothelial cell carcinoma of the bladder.
Arentsen HC; Jansen CF; Hulsbergen-van de Kaa CA; Laihia JK; Pylkkänen L; Leino L; Oosterwijk E; Witjes JA
J Urol; 2012 Apr; 187(4):1445-9. PubMed ID: 22341270
[TBL] [Abstract][Full Text] [Related]
3. Paclitaxel and cisplatin as intravesical agents against non-muscle-invasive bladder cancer.
Hadaschik BA; ter Borg MG; Jackson J; Sowery RD; So AI; Burt HM; Gleave ME
BJU Int; 2008 Jun; 101(11):1347-55. PubMed ID: 18384637
[TBL] [Abstract][Full Text] [Related]
4. Epirubicin and meglumine gamma-linolenic acid: a logical choice of combination therapy for patients with superficial bladder carcinoma.
Harris NM; Anderson WR; Lwaleed BA; Cooper AJ; Birch BR; Solomon LZ
Cancer; 2003 Jan; 97(1):71-8. PubMed ID: 12491507
[TBL] [Abstract][Full Text] [Related]
5. New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin.
Kawano H; Komaba S; Yamasaki T; Maeda M; Kimura Y; Maeda A; Kaneda Y
Cancer Chemother Pharmacol; 2008 May; 61(6):973-8. PubMed ID: 17653716
[TBL] [Abstract][Full Text] [Related]
6. Meglumine Eicosapentaenoic acid (MeEPA) a new soluble omega-3 fatty acid formulation: in vitro bladder cancer cytotoxicity tests in combination with epirubicin and mitomycin.
Mackie SJ; Sharma DM; Cooper AJ; Harris NM; Lwaleed BA
Prostaglandins Leukot Essent Fatty Acids; 2006 Dec; 75(6):367-73. PubMed ID: 16930970
[TBL] [Abstract][Full Text] [Related]
7. Multidrug resistance in a urothelial cancer cell line after 3, 1-hour exposures to mitomycin C.
Speers AG; Lwaleed BA; Featherstone JM; Cooper AJ
J Urol; 2007 Nov; 178(5):2171-5. PubMed ID: 17870115
[TBL] [Abstract][Full Text] [Related]
8. Protodynamic intracellular acidification by cis-urocanic acid promotes apoptosis of melanoma cells in vitro and in vivo.
Laihia JK; Kallio JP; Taimen P; Kujari H; Kähäri VM; Leino L
J Invest Dermatol; 2010 Oct; 130(10):2431-9. PubMed ID: 20520626
[TBL] [Abstract][Full Text] [Related]
9. Molecular targets for the protodynamic action of cis-urocanic acid in human bladder carcinoma cells.
Peuhu E; Kaunisto A; Laihia JK; Leino L; Eriksson JE
BMC Cancer; 2010 Oct; 10():521. PubMed ID: 20920317
[TBL] [Abstract][Full Text] [Related]
10. Two hour exposure to sodium butyrate sensitizes bladder cancer to anticancer drugs.
Wang D; Wang Z; Tian B; Li X; Li S; Tian Y
Int J Urol; 2008 May; 15(5):435-41. PubMed ID: 18452462
[TBL] [Abstract][Full Text] [Related]
11. The effect of platinum analogues and combination chemotherapy on murine bladder cancer.
Soloway MS; Cox CE
Trans Am Assoc Genitourin Surg; 1979; 71():8-13. PubMed ID: 545820
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of paclitaxel released from bio-adhesive polymer microspheres on model superficial bladder cancer.
Le Visage C; Rioux-Leclercq N; Haller M; Breton P; Malavaud B; Leong K
J Urol; 2004 Mar; 171(3):1324-9. PubMed ID: 14767342
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative effects of mistletoe (Viscum album L.) extract in urinary bladder carcinoma cell lines.
Urech K; Buessing A; Thalmann G; Schaefermeyer H; Heusser P
Anticancer Res; 2006; 26(4B):3049-55. PubMed ID: 16886633
[TBL] [Abstract][Full Text] [Related]
14. Interactions of doxycycline with chemotherapeutic agents in human breast adenocarcinoma MDA-MB-231 cells.
Foroodi F; Duivenvoorden WC; Singh G
Anticancer Drugs; 2009 Feb; 20(2):115-22. PubMed ID: 19209028
[TBL] [Abstract][Full Text] [Related]
15. [A case of anaphylactic shock induced by pirarubicin hydrochloride].
Mitsuhashi M; Iwata H; Kiyota A; Kamizuru M; Nakatani T
Hinyokika Kiyo; 2004 Apr; 50(4):257-9. PubMed ID: 15188619
[TBL] [Abstract][Full Text] [Related]
16. The cytotoxic effect of fleroxacin and ciprofloxacin on transitional cell carcinoma in vitro.
Ebisuno S; Inagaki T; Kohjimoto Y; Ohkawa T
Cancer; 1997 Dec; 80(12):2263-7. PubMed ID: 9404703
[TBL] [Abstract][Full Text] [Related]
17. [Bladder cancer: chemotherapy of advanced bladder cancer].
Koiso K
Gan To Kagaku Ryoho; 1982 Mar; 9(3):377-86. PubMed ID: 6820897
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms of action of eicosapentaenoic acid in bladder cancer cells in vitro: alterations in mitochondrial metabolism, reactive oxygen species generation and apoptosis induction.
Colquhoun A
J Urol; 2009 Apr; 181(4):1885-93. PubMed ID: 19237174
[TBL] [Abstract][Full Text] [Related]
19. Differential sensitivities of human testicular and bladder tumor cell lines to chemotherapeutic drugs.
Walker MC; Parris CN; Masters JR
J Natl Cancer Inst; 1987 Aug; 79(2):213-6. PubMed ID: 3474453
[TBL] [Abstract][Full Text] [Related]
20. Modulating effect of mitomycin or cisplatin on lymphokine-activated killer cell proliferation and antitumor activity to bladder cancer cell lines in vitro.
Wang ZP; Qing DS; Shi BG; Chen YR; Liu GD
Zhongguo Yao Li Xue Bao; 1998 Jul; 19(4):369-72. PubMed ID: 10375787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
